|
業務類別
|
Biotechnology |
|
業務概覽
|
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations. |
| 公司地址
| 7707 Gateway Boulevard, Suite 140, Newark, CA, USA, 94560 |
| 電話號碼
| +1 510 474-0170 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.protagonist-inc.com |
| 員工數量
| 132 |
| Dr. Suneel Gupta, PhD |
Executive Vice President, Clinical Development |
美元 530.50K |
06/01/2025 |
| Dr. Dinesh V. Patel, PhD |
Director, President and Chief Executive Officer |
美元 681.41K |
25/02/2026 |
| Dr. Arturo Molina, M.D. |
Chief Medical Officer |
美元 550.00K |
29/04/2025 |
| Mr. Asif Ali |
Executive Vice President, Principal Accounting Officer and Chief Financial Officer |
美元 465.00K |
25/02/2026 |
|
|
| Ms. Sarah A. O’Dowd |
Independent Director |
25/02/2026 |
| Mr. Bryan Giraudo |
Independent Director |
25/02/2026 |
| Dr. Dinesh V. Patel, PhD |
Director, President and Chief Executive Officer |
25/02/2026 |
| Mr. William D. Waddill |
Independent Director |
25/02/2026 |
| Dr. Lewis T. Williams, M.D.,PhD |
Independent Director |
25/02/2026 |
| Dr. Harold E. Selick, PhD |
Chairman of the Board |
25/02/2026 |
|
|
|
|
